Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue doppler imaging Evaluation) randomized pilot study

被引：41
作者：
Lotrionte, Marzia [1 ]
Palazzoni, Giovanni [2 ]
Abbate, Antonio [3 ]
De Marco, Eugenia [1 ]
Mezzaroma, Eleonora [3 ]
Di Persio, Silvia [2 ]
Frati, Giacomo [4 ,5 ]
Loperfido, Francesco [1 ]
Biondi-Zoccai, Giuseppe [4 ]
机构：
[1] Complesso Integrato Columbus, Div Heart Failure & Cardiac Rehabil, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Oncol, I-00168 Rome, Italy
[3] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA
[4] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy
[5] IRCCS Neuromed, Dept AngioCardioNeurol, Pozzilli, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 03期
关键词：
Anthracycline; Cardiotoxicity; Echocardiography; Randomized clinical trial; Tissue Doppler imaging; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; RISK-FACTORS; CHILDREN; FREQUENCY;
D O I：
10.1016/j.ijcard.2012.10.079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1055 / 1057
页数：3
相关论文
共 9 条
  • [1] [Anonymous], 2010, COCHRANE DATABASE SY
  • [2] Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review
    Kremer, LCM
    van der Pal, HJH
    Offringa, M
    van Dalen, EC
    Voûte, PA
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (06) : 819 - 829
  • [3] Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review
    Kremer, LCM
    van Dalen, EC
    Offringa, M
    Voûte, PA
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (04) : 503 - 512
  • [4] Lotrionte M, 2007, Minerva Cardioangiol, V55, P711
  • [5] Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points Rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study
    Lotriontea, Marzia
    Palazzoni, Giovanni
    Natali, Rosaria
    Comerci, Gianluca
    Abbate, Antonio
    Di Persio, Silvia
    Biondi-Zoccai, Giuseppe G. L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (01) : 72 - 77
  • [6] Anthracycline-induced cardiotoxicity
    Shan, K
    Lincoff, AM
    Young, JB
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) : 47 - 58
  • [7] Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
    Smith, Lesley A.
    Cornelius, Victoria R.
    Plummer, Christopher J.
    Levitt, Gill
    Verrill, Mark
    Canney, Peter
    Jones, Alison
    [J]. BMC CANCER, 2010, 10
  • [8] Terracini B, 2010, EPIDEMIOL PREV, V34, P1
  • [9] Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
    Visscher, Henk
    Ross, Colin J. D.
    Rassekh, S. Rod
    Barhdadi, Amina
    Dube, Marie-Pierre
    Al-Saloos, Hesham
    Sandor, George S.
    Caron, Huib N.
    van Dalen, Elvira C.
    Kremer, Leontien C.
    van der Pal, Helena J.
    Brown, Andrew M. K.
    Rogers, Paul C.
    Phillips, Michael S.
    Rieder, Michael J.
    Carleton, Bruce C.
    Hayden, Michael R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1422 - 1428
1